Literature DB >> 20844955

A role for intestinal alkaline phosphatase in the maintenance of local gut immunity.

Kathryn T Chen1, Madhu S Malo, Laura Kline Beasley-Topliffe, Klaas Poelstra, Jose Luis Millan, Golam Mostafa, Sayeda N Alam, Sundaram Ramasamy, H Shaw Warren, Elizabeth L Hohmann, Richard A Hodin.   

Abstract

BACKGROUND AND AIMS: Intestinal alkaline phosphatase (IAP) is a gut mucosal defense factor known to dephosphorylate lipopolysaccharide (LPS); however, the role of IAP in the gut response to luminal bacteria remains poorly defined. We investigated immune responses of wild-type (WT) and IAP-knockout (IAP-KO) mice to LPS and Salmonella typhimurium challenges.
METHODS: Cryostat sectioning and standard indirect immunohistochemical staining for major histocompatibility complex (MHC) class II molecules were performed on liver tissue from WT and IAP-KO mice. WT and IAP-KO mice were orally gavaged with S. typhimurium; bacterial translocation to mesenteric nodes, liver, and spleen was determined by tissue homogenization and plating. In other experiments, WT and IAP-KO mice received intraperitoneal injections of LPS, with subsequent quantification of complete blood counts and serum interleukin (IL)-6 by enzyme-linked immunosorbent assay (ELISA). WT and IAP-KO whole blood were plated and stimulated with LPS and Pam-3-Cys, followed by cytokine assays.
RESULTS: Immunohistologic liver examinations showed increased expression of MHC class II molecules in IAP-KO mice. Following S. typhimurium challenge, WT mice appeared moribund compared with IAP-KO mice, with increased bacterial translocation. WT mice had >50% decrease (P<.005) in platelets and 1.8-fold (P<.05) increased serum IL-6 compared with IAP-KO mice in response to LPS injections. IAP-KO whole-blood stimulation with LPS and Pam-3-Cys resulted in increased IL-6 and tumor necrosis factor (TNF)-alpha secretion compared with WT.
CONCLUSIONS: IAP-KO mice exhibit characteristics consistent with local LPS tolerance. Whole-blood response of IAP-KO mice did not reflect systemic tolerance. These data suggest that IAP is a local immunomodulating factor, perhaps regulating LPS-toll-like receptor 4 (TLR4) interaction between commensal microflora and intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20844955      PMCID: PMC3931260          DOI: 10.1007/s10620-010-1396-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  MECHANISMS OF ENDOTOXIN TOLERANCE. 3. THE REFRACTORY STATE DURING CONTINUOUS INTRAVENOUS INFUSIONS OF ENDOTOXIN.

Authors:  S E GREISMAN; W E WOODWARD
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

2.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo.

Authors:  K Poelstra; W W Bakker; P A Klok; J A Kamps; M J Hardonk; D K Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Randomised controlled study of clinical outcome following trophic feeding.

Authors:  R J McClure; S J Newell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

4.  Release site of TNF alpha after intravenous and intraperitoneal injection of LPS from Escherichia coli in rats.

Authors:  Y Asari; M Majima; K Sugimoto; M Katori; T Ohwada
Journal:  Shock       Date:  1996-03       Impact factor: 3.454

5.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

6.  Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

Authors:  R L Kitchens; P A Thompson; S Viriyakosol; G E O'Keefe; R S Munford
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Regulation of MHC expression in vivo. Bacterial lipopolysaccharide induces class I and II MHC products in mouse tissues by a T cell-independent, cyclosporine-sensitive mechanism.

Authors:  J Jephthah-Ochola; J Urmson; S Farkas; P F Halloran
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

8.  Role of LPS length in clearance rate of bacteria from the bloodstream in mice.

Authors:  A Ohno; Y Isii; K Tateda; T Matumoto; S Miyazaki; S Yokota; K Yamaguchi
Journal:  Microbiology (Reading)       Date:  1995-10       Impact factor: 2.777

Review 9.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.

Authors:  R G Thurman
Journal:  Am J Physiol       Date:  1998-10

10.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

View more
  34 in total

1.  Intestinal alkaline phosphatase to treat necrotizing enterocolitis.

Authors:  Ben E Biesterveld; Shannon M Koehler; Nathan P Heinzerling; Rebecca M Rentea; Katherine Fredrich; Scott R Welak; David M Gourlay
Journal:  J Surg Res       Date:  2015-02-19       Impact factor: 2.192

2.  Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.

Authors:  Sulaiman R Hamarneh; Byeong-Moo Kim; Kanakaraju Kaliannan; Sara A Morrison; Tyler J Tantillo; Qingsong Tao; Mussa M Rafat Mohamed; Juan M Ramirez; Aaron Karas; Wei Liu; Dong Hu; Abeba Teshager; Sarah Shireen Gul; Konstantinos P Economopoulos; Atul K Bhan; Madhu S Malo; Michael Y Choi; Richard A Hodin
Journal:  Dig Dis Sci       Date:  2017-04-19       Impact factor: 3.199

3.  Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.

Authors:  Baomei Shao; Robert S Munford; Richard Kitchens; Alan W Varley
Journal:  Innate Immun       Date:  2012-03-22       Impact factor: 2.680

4.  Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions.

Authors:  David A Shifrin; Russell E McConnell; Rajalakshmi Nambiar; James N Higginbotham; Robert J Coffey; Matthew J Tyska
Journal:  Curr Biol       Date:  2012-03-01       Impact factor: 10.834

5.  Potassium phosphate and potassium carbonate administration by feed or drinking water improved broiler performance, bone strength, digestive phosphatase activity and phosphorus digestibility under induced heat stress conditions.

Authors:  I Ansari; S Khalaji; M Hedayati
Journal:  Trop Anim Health Prod       Date:  2019-08-24       Impact factor: 1.559

6.  Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.

Authors:  Wei Liu; Dong Hu; Haizhong Huo; Weifeng Zhang; Fatemeh Adiliaghdam; Sarah Morrison; Juan M Ramirez; Sarah S Gul; Sulaiman R Hamarneh; Richard A Hodin
Journal:  J Am Coll Surg       Date:  2015-12-18       Impact factor: 6.113

Review 7.  Endotoxemia-menace, marker, or mistake?

Authors:  Robert S Munford
Journal:  J Leukoc Biol       Date:  2016-07-14       Impact factor: 4.962

8.  Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes.

Authors:  Robert J Ardecky; Ekaterina V Bobkova; Tina Kiffer-Moreira; Brock Brown; Santhi Ganji; Jiwen Zou; Ian Pass; Sonoko Narisawa; Flávia Godoy Iano; Craig Rosenstein; Anton Cheltsov; Justin Rascon; Michael Hedrick; Carlton Gasior; Anita Forster; Shenghua Shi; Russell Dahl; Stefan Vasile; Ying Su; Eduard Sergienko; Thomas D Y Chung; Jonathan Kaunitz; Marc F Hoylaerts; Anthony B Pinkerton; José Luis Millán
Journal:  Bioorg Med Chem Lett       Date:  2013-12-19       Impact factor: 2.823

9.  Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain.

Authors:  Ye Yang; José Luis Millán; Joan Mecsas; Karen Guillemin
Journal:  Infect Immun       Date:  2014-10-27       Impact factor: 3.441

10.  Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis.

Authors:  Kevin M Riggle; Rebecca M Rentea; Scott R Welak; Kirkwood A Pritchard; Keith T Oldham; David M Gourlay
Journal:  J Surg Res       Date:  2012-11-08       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.